RxFinder.ai

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

Central Nervous System Stimulant

NADAC/unit $0.2386
Active Shortage

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.

vs. brand Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate: Generic saves up to 98% per unit

Active Shortages

2023-08-15 Estimated recovery: 3 months, Elite Laboratories, Inc.
2022-10-12 Shortage reported, Sandoz Inc.
2022-10-12 Shortage reported, Teva Pharmaceuticals USA, Inc.
2022-10-12 Estimated availability February 2026, Aurobindo Pharma USA
2022-10-12 Estimated recovery: 3 months, Elite Laboratories, Inc.

Market Intelligence

2025-10-01 Class III Recall: Granules Pharmaceuticals Inc.
2025-10-01 Class III Recall: Granules Pharmaceuticals Inc.
2025-10-01 Class III Recall: Granules Pharmaceuticals Inc.
2025-10-01 Class III Recall: Granules Pharmaceuticals Inc.
2025-10-01 Class III Recall: Granules Pharmaceuticals Inc.

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.